General Information of Drug Off-Target (DOT) (ID: OTUCF3GW)

DOT Name Membrane-spanning 4-domains subfamily A member 12 (MS4A12)
Gene Name MS4A12
Related Disease
Colon cancer ( )
Colon carcinoma ( )
Inflammatory bowel disease ( )
Bloom syndrome ( )
Neoplasm ( )
UniProt ID
M4A12_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF04103
Sequence
MMSSKPTSHAEVNETIPNPYPPSSFMAPGFQQPLGSINLENQAQGAQRAQPYGITSPGIF
ASSQPGQGNIQMINPSVGTAVMNFKEEAKALGVIQIMVGLMHIGFGIVLCLISFSFREVL
GFASTAVIGGYPFWGGLSFIISGSLSVSASKELSRCLVKGSLGMNIVSSILAFIGVILLL
VDMCINGVAGQDYWAVLSGKGISATLMIFSLLEFFVACATAHFANQANTTTNMSVLVIPN
MYESNPVTPASSSAPPRCNNYSANAPK
Function May be involved in signal transduction as a component of a multimeric receptor complex.

Molecular Interaction Atlas (MIA) of This DOT

5 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colon cancer DISVC52G Strong Biomarker [1]
Colon carcinoma DISJYKUO Strong Biomarker [1]
Inflammatory bowel disease DISGN23E Strong Genetic Variation [2]
Bloom syndrome DISKXQ7J moderate Genetic Variation [1]
Neoplasm DISZKGEW Disputed Altered Expression [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Membrane-spanning 4-domains subfamily A member 12 (MS4A12). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Membrane-spanning 4-domains subfamily A member 12 (MS4A12). [5]
------------------------------------------------------------------------------------

References

1 Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.Neoplasma. 2017;64(1):65-73. doi: 10.4149/neo_2017_108.
2 CAV3 mutation in a patient with transient hyperCKemia and myalgia.Neurol Neurochir Pol. 2016 Nov-Dec;50(6):468-473. doi: 10.1016/j.pjnns.2016.06.008. Epub 2016 Jul 9.
3 Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.Mol Cancer. 2009 Sep 25;8:77. doi: 10.1186/1476-4598-8-77.
4 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
5 BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res. 2014 Feb 15;20(4):912-25.